Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Safety"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Shi%2C+Yuankai%22&type=Person&filter%5B%5D=topic_facet%3A%22Safety%22
/vufind/Search/Results?lookfor=%22Shi%2C+Yuankai%22&type=Person&filter%5B%5D=topic_facet%3A%22Safety%22
Search /vufind/Search2/Results?lookfor=%22Shi%2C+Yuankai%22&type=Person&filter%5B%5D=topic_facet%3A%22Safety%22
PubPharm (21)
1
Efficacy and safety of geptanolimab (GB226) for relapsed/refractory primary mediastinal large B-cell lymphoma : an open-label phase II study (Gxplore-003)
enthalten in:
Cancer immunology, immunotherapy : CII
| 2023
von
Shi, Y.
|
Cui, J.
|
Zhou, H.
| +16
Wird geladen...
2
Efficacy and safety of geptanolimab (GB226) for relapsed/refractory primary mediastinal large B-cell lymphoma: an open-label phase II study (Gxplore-003)
enthalten in:
Cancer immunology immunotherapy
| 2023
von
Shi, Y.
|
Cui, J.
|
Zhou, H.
| +16
Wird geladen...
3
Efficacy and safety of geptanolimab (GB226) for relapsed/refractory primary mediastinal large B-cell lymphoma: an open-label phase II study (Gxplore-003)
enthalten in:
Cancer immunology immunotherapy
| 2023
von
Shi, Y.
|
Cui, J.
|
Zhou, H.
| +16
Wird geladen...
4
Efficacy and safety of geptanolimab (GB226) for relapsed/refractory primary mediastinal large B-cell lymphoma: an open-label phase II study (Gxplore-003)
enthalten in:
Cancer immunology immunotherapy
| 2023
von
Shi, Y.
|
Cui, J.
|
Zhou, H.
| +16
Wird geladen...
5
Safety, efficacy and pharmacokinetics of BPI-9016M in c-MET overexpression or MET exon 14 skipping mutation patients with locally advanced or metastatic non-small-cell lung cancer : a phase Ib study
enthalten in:
BMC cancer
| 2023
von
Hu, X.
|
Cui, X.
|
Wang, Z.
| +16
Wird geladen...
6
Safety, efficacy and pharmacokinetics of BPI-9016M in c-MET overexpression or MET exon 14 skipping mutation patients with locally advanced or metastatic non-small-cell lung cancer: a phase Ib study
enthalten in:
BMC cancer
| 2023
von
Hu, X.
|
Cui, X.
|
Wang, Z.
| +16
Wird geladen...
7
Safety, efficacy and pharmacokinetics of BPI-9016M in c-MET overexpression or MET exon 14 skipping mutation patients with locally advanced or metastatic non-small-cell lung cancer: a phase Ib study
enthalten in:
BMC cancer
| 2023
von
Hu, X.
|
Cui, X.
|
Wang, Z.
| +16
Wird geladen...
8
Immune checkpoint inhibitors combined with angiogenic inhibitors in the treatment of locally advanced or metastatic lung adenocarcinoma patients
enthalten in:
Cancer immunology, immunotherapy : CII
| 2023
von
Feng, Y.
|
Tang, L.
|
Wang, H.
| +5
Wird geladen...
9
Efficacy and safety of KL-A167 in previously treated recurrent or metastatic nasopharyngeal carcinoma : a multicenter, single-arm, phase 2 study
enthalten in:
The Lancet regional health. Western Pacific
| 2023
von
Shi, Y.
|
Qin, X.
|
Peng, X.
| +41
Wird geladen...
10
Immune checkpoint inhibitors combined with angiogenic inhibitors in the treatment of locally advanced or metastatic lung adenocarcinoma patients
enthalten in:
Cancer immunology immunotherapy
| 2022
von
Feng, Y.
|
Tang, L.
|
Wang, H.
| +5
Wird geladen...
1
2
3
Nächster »
[3]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Safety
Medienart
21
Aufsätze
18
E-Artikel
18
E-Ressourcen
3
Gedruckte Aufsätze
Zeitschriftentitel
6
Cancer immunology immunotherapy
3
BMC cancer
3
Cancer chemotherapy and pharmacology
2
Cancer immunology, immunotherapy : CII
2
Journal of hematology & oncology
2
Journal of thoracic oncology : official publica...
2
Lung cancer (Amsterdam, Netherlands)
1
The Lancet regional health. Western Pacific
Alle anzeigen ...
weniger ...
Thema
Safety
13
Efficacy
9
Journal Article
9
Pharmacokinetics
6
Clinical Trial, Phase I
6
Protein Kinase Inhibitors
5
EC 2.7.10.1
5
Research Support, Non-U.S. Gov't
4
Angiogenic inhibitors
4
Geptanolimab (GB226)
4
Immunotherapy
4
Lung adenocarcinoma
4
Primary mediastinal large B-cell lymphoma
4
Relapsed/refractory
4
Survival
4
Tumor burden
3
BPI-9016M
3
EGFR T790M mutation
3
EGFR protein, human
3
ErbB Receptors
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
16
2020-
5
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
21
Englisch
Haven't found what you're looking for?
Wird geladen...